Don’t miss out on the latest pharmacy insights in the Drug Topics July/August issue.
The July/August 2024 issue of Drug Topics includes important insights on the pivotal rejection of MDMA by an independent FDA Advisory Panel, the importance of patient advocacy in enacting pharmacy change—"Either get into politics or get out of pharmacy," our columnist writes—CDC-backed vaccine recommendations, and more.
To read these stories and more, download the PDF of the Drug Topics July/August 2024 issue here.
Don’t get left behind: Sign up today for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips delivered straight to your inbox.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.